Skip to main content
Tweets by AES2020
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Better Outcomes through Diveristy
Pediatric Highlights Poster
Partners Against Mortality in Epilepsy
Rostam Namdari, PhD
Senior Director, Translational Drug Development
Xenon Pharmaceuticals Inc.
(87) Potential Drug-Drug Interactions Between NBI-921352/XEN901 (a Novel Nav1.6 Selective Sodium Channel Blocker) and a Strong Inducer of CYP3A4 (Phenytoin) in Healthy Volunteers
Saturday, December 5, 2020
9:00 AM – 10:30 AM US EST